Skip to main content
. 2017 Aug 23;106(4):1070–1077. doi: 10.3945/ajcn.117.157545

TABLE 3.

Intervention interactions with baseline age and stunting status1

HAZ
WAZ
Outcome model Unadjusted Adjusted Unadjusted Adjusted
HBGM −0.179 (−0.462, 0.105) −0.042 (−0.283, 0.200) 0.038 (−0.199, 0.274) 0.135 (−0.078, 0.348)
HBGM × stunted growth at baseline 0.565* (0.085, 1.045) 0.582* (0.134, 1.030) 0.146 (−0.358, 0.650) 0.176 (−0.189, 0.541)
HBGM × age <12 mo at baseline 0.164 (−0.220, 0.548) 0.192 (−0.188, 0.573) 0.004 (−0.382, 0.389) 0.069 (−0.216, 0.354)
CBGM+NS −0.442** (−0.746, −0.138) −0.252* (−0.497, −0.007) −0.246# (−0.508, 0.016) −0.160# (−0.341, 0.022)
CBGM+NS × stunted growth at baseline 0.764** (0.251, 1.276) 0.503** (0.160, 0.846) 0.480* (0.050, 0.909) 0.169 (−0.147, 0.485)
CBGM+NS × age <12 mo at baseline 0.223 (−0.223, 0.670) −0.093 (−0.459, 0.274) 0.280 (−0.107, 0.667) 0.056 (−0.251, 0.362)
Stunted growth at baseline −1.550** (−1.878, −1.222) −1.507 (−4.560, 1.546) −1.069** (−1.341, −0.797) −0.879 (−3.033, 1.276)
Age <12 mo at baseline −0.311* (−0.601, −0.022) −0.650 (−3.065, 1.764) −0.228# (−0.490, 0.033) −1.772 (−3.910, 0.366)
Control Ref. Ref. Ref. Ref.
Clusters, n 126 125 126 125
N 497 482 497 481
R2 0.235 0.606 0.172 0.690
1

Results are from multivariate linear regression models. Coefficients represent mean differences (95% CIs). All hypotheses were tested with t tests. Adjusted models include all control variables displayed in Table 1 as well as interaction terms of baseline stunted growth and age <12 mo with all covariates. *Significance at the 5% level. **Significance at the 1% level. #Significance at the 10% level. CBGM+NS, community-based growth monitoring including nutritional supplementation; HAZ, height-for-age z score; HBGM, home-based growth monitoring; Ref., reference category; WAZ, weight-for-age z score.